Ischemic colitis can range from mild inflammation to life-threatening damage. Early diagnosis and tailored care make all the ...

DENVER -- Kris Bryant reached the pinnacle of the baseball world in 2016 with the Chicago Cubs, but it has been downhill since he signed with the Colorado Rockies in 2022. Bryant helped the Cubs ...

Conclusions: Infliximab improved clinical outcomes compared to the previous use of intravenous cyclosporine in patients admitted with steroid-refractory acute severe UC. In 2006, infliximab was ...

31%, p = 0.85). Patients in the acute group had more ECVs (median 3 vs. 2, p < 0.05; ≥3 ECVs 54% vs. 33%, p < 0.01). There was no difference in unsuccessful ECV or subacute recurrence of AF ...

Full Interview Summary: At the recent World Immune Regulatory Conference in Switzerland, Virax Biolabs presented pivotal findings on T cell dysfunction in post-acute infection syndromes (PAIS), such ...

There is a commercial access agreement for ruxolitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Thus, ZZXJD is considered safe in acute and subacute toxicity studies and can be orally administered for at least 28 days without adverse effects. Given that anticancer treatments often involve ...

Antidepressants reverse this suppression, suggesting autophagy as a therapeutic target. Acute stress activates autophagy via AMPK signaling, whereas chronic stress inhibits it through mTOR activation.

Pacritinib showed early activity and was safe for patients with multi-refractory chronic graft-vs-host disease. Pacritinib (Vonjo) yielded preliminary efficacy with an acceptable safety profile for ...